Skip to main content
Decorative image of the AMR Learning Lounge

Diagnostics and Data Can Fill Gaps in Antimicrobial Stewardship Left by COVID-19

SUMMARY

In this article, Brian Raux, PharmD, discusses the global impact COVID-19 has had on the rise of antimicrobial resistance (AMR) and the alarming increase of hospital-acquired infections (HAI). This heightened concern has called for rapid diagnostics and reliable data sharing to mitigate AMR and the spread of infections while helping to improve patient outcomes.

FEATURED EXPERTS

Brian R. Raux, PharmD, BCPS, BCIDP, Medical Science Liaison, U.S. Medical Affairs, bioMérieux


GET STARTED

Read the full Journal of Precision Medicine article.

Read Time: 10 minutes


We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.


Global Solutions

Learn More

U.S. bioMérieux Solutions

US Solutions

BIOFIRE® Respiratory 2.1 and 2.1plus Panels

The BIOFIRE RP2.1 and RP2.1plus Panels use the syndromic approach to accurately detect and identify the pathogens most associated with respiratory infections. Fast and comprehensive results may enable better-informed diagnosis and treatment of patients.

PUBLISHED BY

Journal of Precision Medicine
December 15, 2022


SHARE THIS ARTICLE: